.png)
News | July 19, 2024
Devyser wins tender in Italy for its cystic fibrosis NGS test worth up to 5.9 million SEK
Find out more
All articles
.png)
.png)
One-size-fits-all: Addressing hemoglobinopathy using NGS
.png)
Devyser wins tender in Sweden for Thalassemia NGS testing worth up to 8.4 million SEK
.png)
Streamlining Thalassemia Genetic Testing with NGS: Insights from Cyprus
Devyser announces expanded commercial agreement with Thermo Fisher Scientific for post-transplant monitoring NGS products
Devyser launches updated Y-Chromosomal microdeletion test
Devyser wins all-time high tender for up to 75 MSEK
.png)
Devyser wins tender for oncology NGS solutions in Italy
Devyser wins tender for thalassemia in Italy
Devyser Diagnostics AB publishes quarterly report for the period January to March 2024
.png)
Devyser receives IVDR approval for post-transplant monitoring software
